INSULIN PUMPS (EXTERNAL) - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 13 companies including many key and niche players such as -

Animas Corp.
Debiotech S.A
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic


Click here to request a full list of companies covered in the report...

Code : MCP-1511
Price : $4950
Companies : 13
Pages : 135
Date : March 2014
Market Data Tables : 54
Status: * New Report

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Insulin Pumps: A Prelude.....II-1
The United States – The Largest Market.....II-1
1$100
   Europe – A Market with Vast Potential.....II-2
Rising Incidence of Diabetes – The Driving Factor.....II-2
2$125
   Table 1: Worldwide Prevalence of Diabetes Mellitus by Region: 2013 & 2035 P (includes corresponding Graph/Chart).....II-41$350
   Insulin Pumps Market – Set for Interesting Road Ahead.....II-5 1$100
   Table 2: Global External Insulin Pumps Market by Leading Players (2013): Percentage Market Share Breakdown of Value Sales for Medtronic, Insulet, Roche, J&J (Animas), and Others (includes corresponding Graph/Chart).....II-6

Table 3: Global Market for External Insulin Pumps by Leading Players (2014E): Percentage Share Breakdown of Value Sales for Medtronic, Insulet, Roche, J&J (Animas), Tandem and Others (includes corresponding Graph/Chart).....II-6
Comparison of Select Insulin Pumps by Manufacturer.....II-6
1$350
   Competition Heats Up in the Patch Pumps Market.....II-71$100
   Tough Ground for New Entrants.....II-81$100
   The Rise of Smart Pumps – A Major Game Changer.....II-9
Artificial Pancreas System (APS) – The Future of Diabetes Care.....II-9
1$100
   Type II Diabetes – A Market with Significant Potential.....II-101$100
   The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin
  Pumps.....II-11
1$100
   Table 4: Global Population Statistics for the 65+ Age Group (Male & Female) for Major Countries/Regions: 2013E (includes corresponding Graph/Chart).....II-121$350
   Alarming Rise in Obesity – A Business Case for Diabetes Care.....II-13 1$100
   Table 5: Obesity Rates (%) in OECD Countries (includes corresponding Graph/Chart).....II-141$350
   Table 6: Obese and Overweight & Obese Population in the World (2013): Percentage Share Breakdown by Region for US, European Union, and Rest of World (includes corresponding Graph/Chart).....II-15
Diabetes in Developing Countries to Expand Opportunities.....II-15
1$350
   Innovative Features Spruce Up the Market for Insulin Pumps.....II-16
Patch Pumps Gain Manufacturer Attention.....II-16
ICR: A Key Factor to Success.....II-16
1$100
   Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.....II-17
Teenagers Outdo Adults in Controlling Diabetes.....II-17
Customer Satisfaction: Crucial to Stay Competitive.....II-17
1$100
   Implantable Insulin Pumps – A Potential Threat to External Insulin Pumps.....II-18
Insulin Pump Training - Not Receiving Adequate Attention.....II-18
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.....II-18
1$100
   Competition from Other Insulin Delivery Technologies Continues.....II-19
Undiagnosed Diabetes – A Key Challenge.....II-19
Lantus: A Threat to Insulin Pump Manufacturers.....II-19
1$100
   Diabetes- Incidence And Prevalence.....II-20 1$100
   Table 7: Global Diabetic Population by Region (2013 & 2035) (includes corresponding Graph/Chart).....II-211$350
   Table 8: Top Ten Diabetic Countries (2013) by Number of Individuals with Diabetes (includes corresponding Graph/Chart).....II-22

Table 9: Top Ten Countries by Diabetic Population (2035) (includes corresponding Graph/Chart).....II-22
Diabetes – Assessing the Economic Burden.....II-22
1$350
   Table 10: Diabetes Related Healthcare Expenditure by Region: 2013 (In US$ billion) (includes corresponding Graph/Chart).....II-23
Diabetes Mellitus Cases Worldwide – A Demographic Analysis by Geographic
  Region.....II-23
North America.....II-23
United States.....II-23
Canada.....II-23
1$350
   Mexico.....II-24
Table 11: Prevalence of Diabetes Mellitus in North America (2035 P): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart).....II-24
Europe.....II-24
1$350
   Table 12: Prevalence of Diabetes Mellitus in Europe (2035P): Breakdown by Country, Age Group, and Gender (In Thousand People & %).....II-251$350
   Asia-Pacific.....II-26
Southeast Asian Region.....II-26
Western Pacific Region.....II-26
South & Central America.....II-26
Type-1 Diabetes.....II-26
Type-2 Diabetes.....II-26
1$100
   Diabetes - A Fatal Disease.....II-27
Risk Factors for Diabetes.....II-27
Types of Diabetes.....II-27
1$100
   Long Term Complications of Diabetes.....II-28
Testing Sugar Levels: Easy and Accurate.....II-28
Insulin.....II-28
Pancreas: The Main Source of Insulin in Human Body.....II-28
1$100
   Types of Insulin.....II-29
Types of Insulin & Onset of Action.....II-29
Goal of Insulin Therapy.....II-29
Insulin Delivery Systems.....II-29
1$100
   Table 13: Global Insulin Delivery Devices Market by Leading Players (2013): Percentage Market Share Breakdown for Medtronic, Novo Nordisk, Sanofi and Others (includes corresponding Graph/Chart).....II-30
a. Syringes.....II-30
1$350
   b. Insulin Pens.....II-31
c. Jet Injectors.....II-31
1$100
   d. Tablets.....II-32
e. External Insulin Pumps.....II-32
f. Artificial Pancreas.....II-32
Insulin Delivery Technologies.....II-32
1$100
   Evolution of Insulin Pumps.....II-33
Insulin Pump - A Replica of Pancreas.....II-33
Advantages.....II-33
More Accurate and Consistent.....II-33
1$100
   Enhances Blood Sugar Control in Pediatric Patients.....II-34
Adjusting Time Zones While Traveling.....II-34
Improves Quality of Life.....II-34
Patient Convenience.....II-34
1$100
   Components of Insulin Pump.....II-35
How Does an Insulin Pump Work?.....II-35
Value-added Features of Modern Insulin Pumps.....II-35
Bolus Calculators.....II-35
Insulin On Board.....II-35
1$100
   Customized Alarms.....II-36
Touch Bolus.....II-36
Interface to PCs.....II-36
Others.....II-36
Insulin Pump Delivery Rates.....II-36
Guidelines for Insulin Pump Usage.....II-36
1$100
   Disadvantages/Risks Involved in the Usage of Insulin Pumps.....II-37
High Cost.....II-37
1$100
   High Involvement.....II-38
Diabetic Ketoacidosis Risk.....II-38
Glucose Testing at Regular Intervals.....II-38
Regular Rotation of Infusion Set.....II-38
Carrying Back-up Kit.....II-38
Regular Refilling of Pump.....II-38
1$100
   Debiotech to Unveil Jewel Pump 2.....II-39
Cellnovo Introduces Novel Insulin Pump System.....II-39
J&J Introduces Animas Vibe in Canada.....II-39
Tandem Introduces New Insulin Pump, t:slim, with a Touch Screen.....II-39
1$100
   Roche and Novo Nordisk Team Up for Insulin Pump Cartridge.....II-40
Medtronic Secures FDA Approval for MiniMed 530G.....II-40
LifeScan Acquires Calibra Medical.....II-40
Mediq Takes Over Diabetes Specialty Center.....II-40
Indutrade to Acquire Rubin Medical.....II-40
Cellnovo Obtains CE Mark for Patch Pump.....II-40
1$100
   Asante Secures 510 (K) Approval.....II-41
Medtronic and Bayer HealthCare Expand Collaboration to Cover US Market.....II-41
Insulet Acquires Neighborhood Diabetes.....II-41
JDRF Enters into Partnership with Animas.....II-41
JDRF Collaborates with BD.....II-41
Insulet Inks Exclusive Distribution Agreement with Ypsomed.....II-41
Roche Takes Over Medingo.....II-41
1$100
   Animas Corp. (USA).....II-42
Debiotech S.A. (Switzerland).....II-42
F. Hoffmann-La Roche, Ltd. (Switzerland).....II-42
1$100
   Insulet Corp. (USA).....II-43
Medtronic (USA).....II-43
1$100
   Medtronic Diabetes (USA).....II-44
Sooil Development Co. Ltd. (Korea).....II-44
1$100
   Tandem Diabetes Care Inc. (USA).....II-45
Valeritas Inc. (US).....II-45
Ypsomed Holding AG (Switzerland).....II-45
1$100
   Table 14: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-461$350
   Table 15: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....II-471$350
   Table 16: World 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-481$350
   A. Market Analysis.....III-1
Table 17: US Market Proliferation of Insulin Pumps in Type I Diabetes Treatment (2010-2017P) (includes corresponding Graph/Chart).....III-1
Surging Diabetic Population Spurs Demand.....III-1
1$200
   Table 18: US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart).....III-21$200
   Table 19: US Market for Diabetes Management (2014E & 2017P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart).....III-3

Table 20: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart).....III-3
1$200
   Table 21: US Diabetes Prevalence (in 000’s) for 2010-2017P (includes corresponding Graph/Chart).....III-4

Table 22: Diabetes Prevalence in the US by Type: 2013 (includes corresponding Graph/Chart).....III-4
Artificial Pancreas System (APS): The Future of Diabetes Management.....III-4
1$200
   Select Ongoing Clinical Studies on Artificial Pancreas Technology.....III-5
Competitive Scenario.....III-5
Table 23: The US Insulin Pumps Market by Leading Players (2013): Percentage Market Share Breakdown of Value Sales for Medtronic, Animas (J&J), Insulet, and Others (includes corresponding Graph/Chart).....III-5
1$200
   Table 24: Major Insulin Pump Systems Available in the US.....III-6
Reimbursements.....III-6
1$200
   Regulatory Scenario.....III-7
FDA Announces a New Mandate for Manufacturing Companies.....III-7
Strategic Corporate Developments.....III-7
1$75
   Key Players.....III-83$175
   B. Market Analytics.....III-11
Table 25: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-11
1$200
   Table 26: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-121$200
   A. Market Analysis.....III-13
Product Launch.....III-13
B. Market Analytics.....III-13
Table 27: Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-13
1$200
   Table 28: Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-141$200
   Market Analysis.....III-15
Table 29: Japanese Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-15
1$200
   Table 30: Japanese Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
Regional Scenario.....III-17
Diabetes Prevalence in Europe.....III-17
1$75
   Table 31: Diabetes Mellitus in Europe (2013 & 2035P): Percentage Breakdown of Prevalence in Population by Country (includes corresponding Graph/Chart).....III-181$200
   Table 32: Percentage of Population with Diabetes and Prevalence of Diabetes in the EU (2009-2015) (includes corresponding Graph/Chart).....III-19
Strategic Corporate Developments.....III-19
1$200
   Select Key Players.....III-202$150
   B. Market Analytics.....III-22
Table 33: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-22
1$200
   Table 34: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-231$200
   Table 35: European 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2006, 2012 & 2020 (includes corresponding Graph/Chart).....III-241$200
   Market Analysis.....III-25
Table 36: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-25
1$200
   Table 37: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-261$200
   Market Analysis.....III-27
Table 38: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-27
1$200
   Table 39: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-281$200
   Market Analysis.....III-29
Table 40: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-29
1$200
   Table 41: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
INPUT (The Insulin Pump Therapy Group).....III-31
NICE (National Institute of Clinical Excellence).....III-31
1$75
   Product Launch.....III-32
B. Market Analytics.....III-32
Table 42: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-32
1$200
   Table 43: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-331$200
   Market Analysis.....III-34
Table 44: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 45: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-351$200
   A. Market Analysis.....III-36
Russia.....III-36
Strategic Corporate Developments.....III-36
1$75
   B. Market Analytics.....III-37
Table 46: Rest of European Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-37
1$200
   Table 47: Rest of European Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Table 48: Diabetes Mellitus in Asia-Pacific (2013 & 2035 P): Percentage Breakdown of Prevalence by Select Countries (includes corresponding Graph/Chart).....III-39
1$200
   Review of Select Markets.....III-40
India.....III-40
Diabetes Scenario.....III-40
Insulin Pumps Gather Momentum.....III-40
Medtronic: The Undisputed Market Leader.....III-40
1$75
   Diabetic Epidemic Spurs Indian Market.....III-41
China.....III-41
Overview.....III-41
Competition.....III-41
1$75
   China: An Untapped Goldmine.....III-42
Key Player.....III-42
1$75
   B. Market Analytics.....III-43
Table 49: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-43
1$200
   Table 50: Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Brazil.....III-45
1$75
   B. Market Analytics.....III-46
Table 51: Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-46
1$200
   Table 52: Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
UAE.....III-48
Demand for Insulin Pumps Grows Strongly in the UAE.....III-48
Product Launch.....III-48
1$75
   B. Market Analytics.....III-49
Table 53: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-49
1$200
   Table 54: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-501$200
  
Total Companies Profiled: 13 (including Divisions/Subsidiaries - 16)

Region/Country Players

The United States 10 Europe 4 Asia-Pacific (Excluding Japan) 2
Click here to request a full table of contents and more details on this project.